| Limitations of Basing Screening Policies on Screening Trials | Etzioni, Ruth | 295-300 | 2013.04.23 | - | |
| Counterpoint: Randomized Trials Provide the Strongest Evidence for Clinical Guidelines | Melnikow, Joy | 301-303 | 2013.04.23 | - | |
| Response: Reading Between the Lines of Cancer Screening Trials | Etzioni, Ruth | 304-306 | 2013.04.23 | - | |
| Timeliness of Abnormal Screening and Diagnostic Mammography Follow-up at Facilities Serving Vulnerable Women | Goldman, L. Elizabeth | 307-314 | 2013.04.23 | - | |
| Physicians’ Beliefs About Breast Cancer Surveillance Testing are Consistent With Test Overuse | Han, Paul K. J. | 315-323 | 2013.04.23 | - | |
| When Does an Episode of Care for Cancer Begin? | Hornbrook, Mark C. | 324-329 | 2013.04.23 | - | |
| Variation in Receipt of Radiation Therapy After Breast-conserving Surgery | Feinstein, Aaron J. | 330-338 | 2013.04.23 | - | |
| Cost Comparisons and Methodological Heterogeneity in Cost-of-illness Studies | Ó Céilleachair, Alan J. MEconSc | 339-350 | 2013.04.23 | - | |
| Use and Spending on Antineoplastic Therapy for Medicare Beneficiaries With Cancer | Davidoff, Amy J. | 351-360 | 2013.04.23 | - | |
| Intended Versus Inferred Management After PET For Cancer Restaging | Hillner, Bruce E. | 361-367 | 2013.04.23 | - | |
